Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
TOBACCO-FREE KIDS ACTION FUND

2. Address

Address1
1400 I Street NW
 Address2
​Suite 1200
City
Washington
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Abyot Wondimu
​2022965469
​accounting@tobaccofreekids.org
5. Senate ID#
​401106380-51237
7. Client Name Self Check if client is a state or local government or instrumentality
​TOBACCO-FREE KIDS ACTION FUND
6. House ID#
​454430001
TYPE OF REPORT 8. Year
​2026
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​270,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Abyot Wondimu
 Date
10/20/2026 2:15:27 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOB

16. Specific lobbying issues

Lobbying Report: July 1st - September 30th , 2026 (Action Fund)
Federal (under tobacco issue code)  
Legislation:  
H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act)
H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act)
H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act
H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act
H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act
H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act
S. 4257 Resources to Prevent Youth Vaping Act
H.R. 7567 Farm, Food, and National Security Act of 2026
S. 5526 Agricultural Act of 2026
H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
H.R. 9877/S.5066 Health, Equity, and Accountability Act of 2026
H.R. 10068/S.5312 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act
Issues:
CDC tobacco prevention and cessation programs and funding
Congressional Caucus to End Youth Vaping
Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes
FDA oversight of nicotine pouches
FDA regulation of tobacco products[LG1.1]
Potential Flavors Legislation
Potential [LG2.1]Tobacco Control Legislation
Regulation of Menthol Cigarettes
Tobacco Impact on Maternal Health
Tobacco Graphic Warnings
Tobacco User Fees
OMB Federal financial Assistance Rule [LG3.1]
Tobacco Harm Reduction
Modified Risk Tobacco Products
Agencies Visited:  
Food and Drug Administration 
US House of Representatives  
US Senate
Office of Management and Budget
Centers for Disease Control and Prevention

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Brian J
Hickey
​
Sen. Dick Durbin Leg. Asst. for Hlth Policy & Soc. Sec. 2007-2009 Senate Dem. Policy Comte. Policy Adv. 2002-2007 Sen. Edward Kennedy (Hlth, Educ. and Pensions Cmte. 2001-2002
Luke C.
George
​
Congressman Martin Frost Legislative Assistant and Systems Manager April 2003 to January 2005 Congressman Lloyd Doggett Legislative Assistant and Systems Manager January 2005 to July 2007
Amani
Desamours
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

GHAI Overdose Initiative (under healthcare issue code):
Legislation:
FY 27 Appropriations bills
H.R. 5629- To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
H.R. 5630- To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
H.R. 2741 - PEER Support Act
S.2948 - WORK to Save Lives Act
S. 3522 - No Red Tape Act
H.R. 2741/ S. 1329 - Providing Empathetic and Effective Recovery (PEER) Support Act
H.R. 2586 - Reentry Act
H.R. 1510/ S. 1720 - Due Process Continuity of Care Act
S. 5425 - Addiction Grants Modernization Act
H.R. 9790/S.4941 - Modernizing Opioid Treatment Access Act 2.0

Issues:
Medicaid prior authorization requirements
Access to addiction treatment services
Overdose prevention
Racial disparities in overdose deaths
Federal grant funding for addiction treatment services and harm reduction interventions
Financing (grants) for behavioral health care services and programs
Medicaid and Medicare coverage for addiction treatment services
Medicaid funding and federal guidance related to harm reduction
Medicaid-supported services during incarceration
Congressional naloxone training
Women in recovery
Substance use disorder workforce expansion
CDC Injury Prevention Center programs and funding
Methadone access

Agencies Visited:
US House of Representatives
US Senate


17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elizabeth
Jones
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address: www.tobaccofreekids.org

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
Campaign for Tobacco-Free Kids
1400 I Street NW Suite 1200
Washington DC 20005 USA
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)